Complementary in vitro and in vivo study of the promising combined treatment modality of ionizing radiation and patupilone (EPO906, epothilone B)

被引：0
|
作者：
Hofstetter, B
Oehler, C
Vuong, V
Broggini-Tenzer, A
Ciernik, IF
Wergin, M
Wartmann, M
Rüetz, S
McSheehy, P
Pruschy, M
机构：
[1] Univ Zurich Hosp, Dept Radiat Oncol, Zurich, Switzerland
[2] Novartis Inst BioMed Res, Basel, Switzerland
来源：
RADIOTHERAPY AND ONCOLOGY | 2006年 / 78卷
关键词：
D O I：
10.1016/S0167-8140(06)80627-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
148
引用
收藏
页码：S49 / S50
页数：2
相关论文
共 15 条
  • [1] Effects of patupilone (epothilone B; EPO906), a novel chemotherapeutic agent, in hepatocellular carcinoma: An in vitro study
    Mok, Tony S. K.
    Choi, Eve
    Yau, Daisy
    Johri, Anandhi
    Yeo, Winnie
    Chan, Anthony T. C.
    Wong, Cesar
    ONCOLOGY, 2006, 71 (3-4) : 292 - 296
  • [2] Patupilone (epothilone B, EPO906) inhibits growth and metastasis of experimental prostate tumors in vivo
    O'Reilly, T
    McSheehy, PMJ
    Wenger, F
    Hattenberger, M
    Muller, M
    Vaxelaire, J
    Altmann, KH
    Wartmann, M
    PROSTATE, 2005, 65 (03): : 231 - 240
  • [3] Effects of patupilone (epothilone B; EPO906), a novel chemotherapeutic agent, in hepatocellular carcinoma: An in-vitro study
    Choi, Eve P.
    Yau, Daisy M. S.
    Wong, Cesar S. C.
    Mok, Tony S. K.
    CANCER RESEARCH, 2006, 66 (08)
  • [4] EPO906 (Epothilone B): A promising novel microtubule stabilizer
    Rothermel, J
    Wartmann, M
    Chen, TL
    Hohneker, J
    SEMINARS IN ONCOLOGY, 2003, 30 (03) : 51 - 55
  • [5] Different scheduling of combined treatment with ionizing radiation and Patupilone (EPO 906) in a xenograft colon cancer model
    Hofstetter, B.
    Oehler, C.
    Vuong, V.
    Ruetz, S.
    McSheehy, P.
    Jochum, W.
    Pruschy, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 : 167 - 167
  • [6] EPO906 (Epothilone B) inhibits cell growth and survival of multiple myeloma cells in the bone marrow microenvironment, in vitro and in vivo.
    Lin, BK
    Catley, LP
    LeBlanc, R
    Gupta, D
    Burger, R
    Tai, YT
    Podar, K
    Wartmann, M
    Griffin, JD
    Anderson, KC
    BLOOD, 2002, 100 (11) : 818A - 818A
  • [7] A phase I clinical and pharmacokinetic study of EPO906 (epothilone B) in patients with advanced solid tumours.
    Calvert, PM
    O'Neill, V
    Azzabi, A
    Hughes, A
    Plummer, R
    Twelves, C
    Robinson, A
    Machan, MA
    Dimitrijevic, S
    Moss, D
    Rothermel, J
    Cohen, P
    Chen, T
    Man, A
    Calvert, AH
    CLINICAL CANCER RESEARCH, 2000, 6 : 4581S - 4581S
  • [8] Patupilone (epothilone B, EPO906) and imatinib (STI571, Glivec) in combination display enhanced antitumour activity in vivo against experimental rat C6 glioma
    O'Reilly, T
    Wartmann, M
    Maira, SM
    Hattenberger, M
    Vaxelaire, J
    Muller, M
    Ferretti, S
    Buchdunger, E
    Altmann, KH
    McSheehy, PMJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (04) : 307 - 317
  • [9] Patupilone (epothilone B, EPO906) and imatinib (STI571, Glivec) in combination display enhanced antitumour activity in vivo against experimental rat C6 glioma
    T. O’Reilly
    M. Wartmann
    S.-M. Maira
    M. Hattenberger
    J. Vaxelaire
    M. Muller
    S. Ferretti
    E. Buchdunger
    K.-H. Altmann
    P. M. J. McSheehy
    Cancer Chemotherapy and Pharmacology, 2005, 55 : 307 - 317
  • [10] In vitro and in vivo experimental models of epothilone B (EPO-B) neurotoxicity: Results of a pilot study
    Gilardini, A.
    Cavaletti, G.
    Nicolini, G.
    Canta, A.
    Carozzi, V
    Cossa, G.
    Oggioni, N.
    Bossi, M.
    Tredici, G.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2007, 12 (02) : 158 - 158
12